Strides gets USFDA acclaim for Ibuprofen Oral Suspension

Strides gets USFDA acclaim for Ibuprofen Oral Suspension

by admin- Monday, May 30th, 2022 05:02:13 PM

Strides Pharma Science introduced that its stepdown fully owned subsidiary, Strides Pharma Global Pte. Ltd, Singapore, has received popularity of Ibuprofen Oral Suspension USP, 100 mg/five mL from the US Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equal to the Reference Listed Drug (RLD), Motrin Oral Suspension, one hundred mg/5 mL, of McNeil Consumer Healthcare (McNeil).

The product will be manufactured on the company’s facility at Bengaluru and can be marketed by using Strides Pharma Inc. Within the US marketplace.

News Updates